Literature DB >> 1919611

Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases.

H Krüger1, E Heim, B Schuknecht, S Scholz.   

Abstract

Of the 96 serologically confirmed neuroborreliosis cases seen in our clinic between 1983 and 1988, 11 patients had mild to moderate and 4 patients had serious cerebral and/or spinal cord symptoms. Nine of these 15 patients with CNS involvement exhibited a primary chronic course of the illness. After high-dose intravenous therapy with penicillin, doxycycline or cefotaxime, given mostly in combination with cortisone, gradual recovery occurred with normalization of CSF findings characteristic of neuroborreliosis, and normalization of significantly elevated Borrelia burgdorferi IgG antibody titres in CSF and serum. Brain MRI and CT showed evidence of or were suggestive of vascular involvement which correlated with clinical symptoms in 11 of the 15 patients with CNS involvement. Brain MRI changes that were similar but much slighter in number and intensity were seen in 5 of 12 neuroborreliosis patients without clinical signs of CNS involvement (lymphocytic meningoradiculitis; Bannwarth's syndrome). The frequencies of the HLA-DR7 (75%), HLA-B44 (50%) and HLA-A29 (33%) antigens in 12 neuroborreliosis patients with clinical symptoms of CNS involvement were significantly different from the frequencies in 12 neuroborreliosis patients without CNS involvement and in 100 control subjects. Diagnostic criteria of active neuroborreliosis are proposed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919611     DOI: 10.1007/bf00319739

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  55 in total

1.  Follow-up of antibiotically treated and untreated neuroborreliosis.

Authors:  H Krüger; W Kohlhepp; S König
Journal:  Acta Neurol Scand       Date:  1990-07       Impact factor: 3.209

2.  [MENINGO-MYELO--RADICULITIS AFTER A TICK BITE WITH ERYTHEMA].

Authors:  H BAMMER; K SCHENK
Journal:  Dtsch Z Nervenheilkd       Date:  1965-05-03

3.  Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection.

Authors:  P A Uldry; F Regli; J Bogousslavsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

4.  [Predominant involvement of the central nervous system in a secondary form of borreliosis].

Authors:  M Bataillard; C Bernard; A Cardey; M Cotte Rittaud; P Hanhart
Journal:  Rev Neurol (Paris)       Date:  1988       Impact factor: 2.607

5.  HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility.

Authors:  S Scholz; E Albert
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  HLA-DR in meningopolyneuritis of Garin-Bujadoux-Bannwarth: contrast to Lyme disease?

Authors:  W Kristoferitsch; W R Mayr
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

7.  Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome).

Authors:  A Henriksson; H Link; M Cruz; G Stiernstedt
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

8.  Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  K Hansen; M Cruz; H Link
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

9.  CNS-borreliosis selectively affecting central motor neurons.

Authors:  S Fredrikson; H Link
Journal:  Acta Neurol Scand       Date:  1988-09       Impact factor: 3.209

10.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more
  12 in total

1.  Is CNS involvement in acute and chronic neuroborreliosis HLA-related?

Authors:  C D Reimers; K H Pflüger
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

Review 2.  Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.

Authors:  A Sadziene; A G Barbour
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 3.  Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature review.

Authors:  M Wilke; H Eiffert; H J Christen; F Hanefeld
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

4.  Simultaneous involvement of third and sixth cranial nerve in a patient with Lyme disease.

Authors:  M Lell; A Schmid; B Stemper; C Maihöfner; J G Heckmann; B F Tomandl
Journal:  Neuroradiology       Date:  2002-12-18       Impact factor: 2.804

5.  Relationship between the Borrelia burgdorferi specific immune response and different stages and syndromes in neuroborreliosis.

Authors:  P Oschmann; H J Wellensiek; W Zhong; W Dorndorf; K W Pflughaupt
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

Review 6.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

7.  Childhood neuroborreliosis: clinicoradiological correlation.

Authors:  P Demaerel; G Wilms; K Casteels; P Casaer; J Silberstein; A L Baert
Journal:  Neuroradiology       Date:  1995-10       Impact factor: 2.804

Review 8.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030

9.  Brainstem abnormalities and vestibular nerve enhancement in acute neuroborreliosis.

Authors:  Nadja A Farshad-Amacker; Hans Scheffel; Thomas Frauenfelder; Hatem Alkadhi
Journal:  BMC Res Notes       Date:  2013-12-21

10.  Chronic or late lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis.

Authors:  Judith Miklossy
Journal:  Open Neurol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.